Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Reshaping Early Identification and Diagnosis of Heart Failure
Author(s): Giuseppe Rosano, Lisa Anderson, Antoni Bayés-Genís Start date: May 13, 2024
Join us live from the Heart Failure Association (HFA) meeting 2024, for an exclusive discussion between Prof Giuseppe Rosano (St George's Hospital, London, UK), Dr Lisa Anderson (St George's Hospital, London, UK) and Prof Antoni Bayes-Genis (Hospital Germans Trias i Pujol, Barcelona, ES).Our panel will focus on the latest real-world data in the diagnosis and treatment of heart failure (HF) from… View more

Heart Failure
AHA 24: The REMS Program for Mavacamten
Author(s): Milind Y Desai Added: 1 year ago
AHA Conference 2024 - 22 month data from the risk evaluation and mitigation strategy (REMS) program for mavacamten (Camzyos; Bristol-Myers Squibb Company) in hypertrophic cardiomyopathy (HCM) patients.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at AHA Conference to discuss the findings from the REMS program for mavacamten.The REMS program investigated the safety and efficacy of… View more

Heart Failure
Research Area(s) / Expertise: Job title: Consultant and Professor of Cardiology
Personal History Professor Ross Jacob Hunter was born in 1977 in the UK. He is a Consultant Cardiologist specialising in arrhythmia management and the clinical lead for AF services at The Barts Heart Centre.3 Academic History Prof Hunter earned his BSc in Cardiovascular Medicine from Imperial College London in 1998. In 2001, he was awarded an MBBS with a distinction from Guy’s Kings … View more
NHC 2026
Author(s): Iacopo Olivotto, Rodney Falk, Margot K Davis Start date: May 27, 2026

CV Disease in Special Populations

Heart Failure
NHC 2026
Author(s): Iacopo Olivotto, Rodney Falk, Margot K Davis Start date: May 26, 2026

CV Disease in Special Populations

Heart Failure
Immune Cell Traits and Heart Failure: A Mendelian Randomisation Study
Author(s): Wei Gao , Hui Wang , Jian-long Wang , et al Added: 5 months ago

Demographic

Heart Failure
AHA Scientific Sessions 2025 Late-Breaking and Featured Science Collection
Author(s): Nicolas M Van Mieghem Added: 5 months ago
Stay at the forefront of cardiovascular medicine with our comprehensive video collection from the American Heart Association's Scientific Sessions 2025. Access expert analysis of the most impactful late-breaking trials and featured science shaping clinical practice.Late-Breaker Discussions: Watch Dr Harriette Van Spall break down pivotal clinical trial data and explore its implications for… View more

Intervention

Cardiovascular Renal Metabolic
ESC HF 25: TIM-HF2 Pre-specified Analysis
Author(s): Stefan Stork Added: 10 months ago
ESC HF 25 - A secondary analysis of TIM-HF2 showed that patients residing farther from their cardiologist benefited further from remote patient management (RPM).Prof Stefan Störk (University Hospital Wuerzburg, DE) discusses the findings from a pre-specified, secondary analysis of TIM-HF2, investigating the impact of rurality and travel distance on the effectiveness of RPM in patients… View more

Digital Health

Heart Failure
Biological Aging, AI & the Brain-Heart Connection
Author(s): Dipti Itchhaporia , Valentin Fuster Added: 1 year ago
In this exclusive episode of the "Innovations in Cardiology" podcast series, host Dr Dipti Itchhaporia, past president of the American College of Cardiology, delves into the latest advancements in cardiovascular health. She is joined by Dr Valentin Fuster, a pioneer in the field, who shares invaluable insights into the impact of biological ageing, the connection between the heart and brain, and… View more

Digital Health

Heart Failure
AHA 25: MAPLE-HCM Responder Analysis
Author(s): Andrew Wang Added: 5 months ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive… View more

Heart Failure